Search

Your search keyword '"Rozsypal H"' showing total 119 results

Search Constraints

Start Over You searched for: Author "Rozsypal H" Remove constraint Author: "Rozsypal H"
119 results on '"Rozsypal H"'

Search Results

3. Estimating prevalence of accumulated HIV-1 drug resistance in a cohort of patients on antiretroviral therapy

10. [A case of tuberculous meningitis associated with persistently reduced CD4+ T lymphocyte counts]

11. Pokroky a úskalí v lé& #269;b& #283; chronické HCV infekce.

12. Variable impact on mortality of AIDS-defining events diagnosed during combination antiretroviral therapy : not all AIDS-defining conditions are created equal

13. Vitamin D and clinical disease progression in HIV infection: results from the EuroSIDA study

14. Estimating prevalence of accumulated HIV-1 drug resistance in a cohort of patients on antiretroviral therapy

15. A standardized algorithm for determining the underlying cause of death in HIV infection as AIDS or non-AIDS related: results from the EuroSIDA study

16. A comparison of the long-term durability of nevirapine, efavirenz and lopinavir in routine clinical practice in Europe: a EuroSIDA study

17. History of viral suppression on combination antiretroviral therapy as a predictor of virological failure after a treatment change

18. Predicting the risk of cardiovascular disease in HIV-infected patients: the data collection on adverse effects of anti-HIV drugs study

19. Relationship between current level of immunodeficiency and non-acquired immunodeficiency syndrome-defining malignancies

20. Serious Fatal and Nonfatal Non-AIDS-Defining Illnesses in Europe

21. High prevalence of the metabolic syndrome in HIV-infected patients: impact of different definitions of the metabolic syndrome

22. Estimated glomerular filtration rate, chronic kidney disease and antiretroviral drug use in HIV-positive patients

23. Dialysis and renal transplantation in HIV-infected patients: a European survey

24. Comparison of genotypic resistance profiles and virological response between patients starting nevirapine and efavirenz in EuroSIDA

25. Does short-term virologic failure translate to clinical events in antiretroviral-naïve patients initiating antiretroviral therapy in clinical practice?

26. HIV-induced immunodeficiency and mortality from AIDS-defining and non-AIDS-defining malignancies

27. Changes over time in risk factors for cardiovascular disease and use of lipid-lowering drugs in HIV-infected individuals and impact on myocardial infarction

28. Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:A:D study: a multi-cohort collaboration

29. Importance of baseline prognostic factors with increasing time since initiation of highly active antiretroviral therapy: collaborative analysis of cohorts of HIV-1-infected patients

36. First Detection of Chlamydia trachomatis LGV Biovar in The Czech Republic, 2010-2011.

37. Are Specific Antiretrovirals associated with an Increased Risk of Discontinuation due to Toxicities or Patient/Physician Choice in patients with Hepatitis C Virus Coinfection?

38. Thymidine Analogue Mutation Profiles: Factors Associated with Acquiring Specific Profiles and their Impact on the Virological Response to Therapy

39. Baseline Resistance and Virological Outcome in Patients with Virological Failure who Start a Regimen Containing Abacavir: Eurosida Study

40. Response to Antiretroviral Therapy among Patients Exposed to Three Classes of Antiretrovirals: Results from the Eurosida Study

41. Bilateral Holmes-Adie syndrome as an early manifestation of the HIV neuropathy.

44. Incidence of tuberculosis among HIV-infected patients receiving highly active antiretroviral therapy in Europe and North America

48. [Recommendation for diagnostics and therapy of toxoplasmosis in persons with HIV infection]

Catalog

Books, media, physical & digital resources